Director, Investor Relations

LeMaitre•Burlington, MA

About The Position

Reporting to the CFO, the Director, Investor Relations leads the day-to-day execution of LeMaitre Vascular’s investor relations program and supports selected financial planning and analysis activities. The role coordinates quarterly earnings and investor events, develops investor communications, monitors market expectations and shareholder sentiment, and serves as a day-to-day contact for sell-side analysts and selected investors. Working closely with the CFO, CEO, Accounting, Legal, Finance, and business leaders, the Director ensures external communications are accurate, consistent, and compliant with Company disclosure policies. The Director supports the CFO with the Company’s most significant investor and analyst relationships and leads IR communications for the broader shareholder base and external relationships, including presenting at select conferences and representing the Company externally. Approximately 75% of the role focuses on investor relations: executing the IR strategy and annual calendar; coordinating earnings materials and events; maintaining investor-facing materials and website content; analyzing consensus estimates, shareholder ownership, trading activity, peers, industries, valuation, and capital markets; presenting at conferences and non-deal roadshows; managing analyst relationships and investor records; and ensuring communications comply with Regulation FD and Company policies. Approximately 25% of the role supports financial analysis and planning, including annual planning, forecasting, performance and variance analysis, financial modeling, and analytical support for acquisitions, capital allocation, strategic initiatives, and capital-markets activities.

Requirements

Bachelor’s degree in finance, accounting, economics, business, or a related field.
At least 3 years of relevant experience in investor relations or equity research, or 5+ years in investment banking, corporate finance, FP&A, or a related field.
Exceptional written and verbal communication skills, including the ability to translate complex financial, commercial, clinical, and operational information into clear, credible investor communications.
Strong understanding of financial statements, accounting concepts, financial modeling, valuation methodologies, and public-company performance metrics.
Demonstrated executive presence and ability to interact credibly with institutional investors, sell-side analysts, executives, and Board members.
Strong analytical judgment and ability to identify principal drivers of financial performance and investor perception.
Strong project-management and organizational skills, including coordinating multiple contributors and meeting immovable earnings and disclosure deadlines.
High level of discretion, integrity, attention to detail, and judgment in handling confidential and potentially material information.
Strong interpersonal skills and ability to collaborate with personnel across all levels of the organization.

Nice To Haves

MBA preferred.
Meaningful public-company investor relations or Wall Street-facing experience, including direct interaction with institutional investors and sell-side research analysts.
Experience supporting quarterly earnings, financial guidance, investor presentations, and other public-company communications.
Medical device, life sciences, or healthcare experience.

Responsibilities

Lead day-to-day execution of the Company’s investor relations strategy and annual IR calendar.
Lead development and coordination of quarterly earnings materials, including releases, prepared remarks, investor presentations, anticipated Q&A, executive briefing materials, and earnings-call logistics.
Develop and maintain the corporate investor presentation, investor fact sheet, investor website content, and other investor-facing materials.
Develop analytical models and tools for management’s guidance-setting process; maintain a detailed consensus model and monitor sell-side estimates, valuation assumptions, and investor expectations.
Conduct peer-company, industry, valuation, and capital-markets analysis; synthesize relevant competitive, clinical, reimbursement, and end-market developments for management.
Analyze shareholder base, trading activity (13-F), and institutional ownership, and develop plans to reach appropriate long-term shareholders.
Present at investor conferences and conduct non-deal roadshow (NDR) meetings.
Prepare executives for investor conferences, meetings, and events, and represent the Company at selected events as delegated by the CFO.
Maintain sell-side research analyst relationships, respond to routine inquiries using publicly disclosed information and approved messaging, and cultivate prospective analysts to broaden appropriate research coverage.
Maintain investor CRM records, meeting history, notes, follow-up items, and outreach activity; coordinate investor visits and analyst days.
Work with the CFO, Legal, and Accounting to ensure investor communications are accurate, consistent with Company disclosures, and compliant with Regulation FD and Company disclosure policies.
Support investor communications related to acquisitions, capital allocation, debt and equity financings, and other significant corporate developments.
Support the CFO with coordination, logistics, travel, and administrative tasks for investor meetings, NDRs, conferences, and other events.
Support annual planning and periodic forecasting, with focus on aligning internal financial outlook, external guidance, and investor communications.
Perform financial and operating analysis to identify drivers of revenue, gross margin, operating expenses, earnings, cash flow, and quarterly performance.
Support quarterly performance and variance analysis and translate financial results into clear internal and external messaging.
Develop financial models, peer analyses, and other decision-support materials.
Provide targeted analytical support for acquisitions, capital-allocation decisions, strategic initiatives, and capital-markets activities.